Study on Fear of Movement After Total Knee Arthroplasty

A Survey of Fear of Exercise and Its Influencing Factors in Patients After Total Knee Arthroplasty

Total knee arthroplasty is one of the effective methods for the treatment of end-stage osteoarthritis. Postoperative rehabilitation exercise is an important method for the recovery of knee joint function. Exercise fear refers to an enlarged psychological phenomenon that patients are afraid of sports leading to injury, which is not conducive to the functional exercise of patients and hinders the recovery of knee joint function

Study Overview

• Status: Recruiting
• Conditions: Total Knee Arthroplasty
• Intervention / Treatment: Other: patients were exposed to fear of movement; Other: patients were not exposed to fear of movement

Detailed Description

Object: the purpose of this study is to investigate the occurrence of fear of movement after total knee arthroplasty and analyze its influencing factors, so as to provide theoretical basis for reducing the occurrence of fear of movement after total knee arthroplasty, promoting the rehabilitation exercise of patients and promoting the recovery of knee joint function.

In this study, 121 patients with total knee arthroplasty were investigated by questionnaire, including general demographic data, sports fear scale, anxiety and depression scale, self-efficacy scale and so on. Multivariate logistic regression was used to analyze the influencing factors of postoperative fear of exercise.

• Study Type: Observational
• Enrollment (Anticipated): 121

Contacts and Locations

• Study Contact: Name: Tao Li; Phone Number: 13811397872; Email: tobetheone@126.com

Study Locations

• China
  • Beijing, China
    • Recruiting
    • Peking University Third Hospital
    • Contact: Taobao Li; Phone Number: 13811397872

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients after total knee arthroplasty

Description

Inclusion Criteria:

（1） meeting the criteria of knee arthritis established by American Society of rheumatology （ 2) Total knee arthroplasty was performed for the first time （ 3) Good Chinese reading and comprehension ability （ 4) The patient's condition was stable, and there were no serious diseases of the heart, lung, brain and other important organs （ 5) Informed of the study and signed informed consent.

Exclusion Criteria:

（1）deep venous thrombosis of lower extremity （ 2) Other diseases affecting walking function （ 3) Suffering from cognitive or mental disorders （ 4) Had a history of knee surgery

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
fear of movement group; The score of fear of movement scale was more than 37	Other: patients were exposed to fear of movement; Patients completed the questionnaires independently
non-fear of movement group; The score of fear of movement scale was no more than 37	Other: patients were not exposed to fear of movement; Patients completed the questionnaires independently

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The occurrence of fear of movement	Score of Tampa for kinesiophobia(TSK) ranging from17-68.The higher score means the worse outcome	2nd day post-operative

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Hospital Ansiety and Depression Scale(HADS)	The score of HADS ranging from 0-48,the higher score means the worse outcome	2nd day post-operative
General Self Efficacy Scale(GSES)	The score of GSES,ranging from 1-40,the higher socre means the better outcome	2nd day post-operative

Collaborators and Investigators

• Sponsor: Peking University Third Hospital
• Investigators: Principal Investigator: Tao Li, Peking University Third Hospital

Study record dates

Study Major Dates

• Study Start (Actual): March 25, 2021
• Primary Completion (Anticipated): September 25, 2021
• Study Completion (Anticipated): September 25, 2021

Study Registration Dates

• First Submitted: June 27, 2021
• First Submitted That Met QC Criteria: July 8, 2021
• First Posted (Actual): July 15, 2021

Study Record Updates

• Last Update Posted (Actual): July 15, 2021
• Last Update Submitted That Met QC Criteria: July 8, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: M2021182

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No